1. Home
  2. BLRX vs SAIH Comparison

BLRX vs SAIH Comparison

Compare BLRX & SAIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • SAIH
  • Stock Information
  • Founded
  • BLRX 2003
  • SAIH 2019
  • Country
  • BLRX Israel
  • SAIH Singapore
  • Employees
  • BLRX N/A
  • SAIH N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • SAIH
  • Sector
  • BLRX Health Care
  • SAIH
  • Exchange
  • BLRX Nasdaq
  • SAIH NYSE
  • Market Cap
  • BLRX 12.1M
  • SAIH 13.4M
  • IPO Year
  • BLRX 2011
  • SAIH N/A
  • Fundamental
  • Price
  • BLRX $5.74
  • SAIH $6.98
  • Analyst Decision
  • BLRX Strong Buy
  • SAIH
  • Analyst Count
  • BLRX 2
  • SAIH 0
  • Target Price
  • BLRX $19.00
  • SAIH N/A
  • AVG Volume (30 Days)
  • BLRX 2.0M
  • SAIH 44.2K
  • Earning Date
  • BLRX 05-27-2025
  • SAIH 04-28-2025
  • Dividend Yield
  • BLRX N/A
  • SAIH N/A
  • EPS Growth
  • BLRX N/A
  • SAIH N/A
  • EPS
  • BLRX N/A
  • SAIH N/A
  • Revenue
  • BLRX $22,340,000.00
  • SAIH $5,543,000.00
  • Revenue This Year
  • BLRX N/A
  • SAIH N/A
  • Revenue Next Year
  • BLRX N/A
  • SAIH N/A
  • P/E Ratio
  • BLRX N/A
  • SAIH N/A
  • Revenue Growth
  • BLRX 91.68
  • SAIH N/A
  • 52 Week Low
  • BLRX $2.30
  • SAIH $3.00
  • 52 Week High
  • BLRX $35.60
  • SAIH $26.98
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 73.10
  • SAIH N/A
  • Support Level
  • BLRX $3.88
  • SAIH N/A
  • Resistance Level
  • BLRX $7.77
  • SAIH N/A
  • Average True Range (ATR)
  • BLRX 0.75
  • SAIH 0.00
  • MACD
  • BLRX 0.19
  • SAIH 0.00
  • Stochastic Oscillator
  • BLRX 56.81
  • SAIH 0.00

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About SAIH SAIHEAT LIMITED

Saiheat Ltd develops technologies for the Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations. The Company has four reportable segments: equipment sales, hosting, mining pool business, and mining.

Share on Social Networks: